Stock · NSE
ZYDUSLIFE 1,159.50 ▲ 20.50 (1.80%) Last 2 days · 15m candles 9/10/2026, 02:53:35
Open: 1,139.10 High: 1,163.90 Low: 1,139.00 Prev: 1,139.00
News mentioning ZYDUSLIFE VERIFIED Mint Markets · 15h ★ ON YOUR LIST ☆
AMFI Rejig: Lenskart, LG Electronics, Siemens Energy among 6 stocks set for largecap upgrade AI summary · NEUTRAL
· Nuvama anticipates Bosch, Siemens Energy, Lodha, Zydus Life, Lenskart, and LG Electronics may be upgraded to large-cap status by AMFI in February 2027. · These potential upgrades are based on current market capitalization levels. · The final reclassification will be determined by stock rankings from July to December 2026. VERIFIED ET Finance · 2d ★ ON YOUR LIST ☆
Product's form at sale, not end use, will determine tax rate: Supreme Court AI summary · NEUTRAL
· The Supreme Court ruled that the tax rate depends on a product's physical form at sale, not its end use. · The court dismissed revenue appeals concerning Cadila Healthcare's GRD Powder and GRD Mix. · The revenue department sought to tax these products as non-alcoholic beverages at 10%. VERIFIED ET Markets · 3d ★ ON YOUR LIST ☆
Stocks in news: Vedanta, Kotak Mahindra Bank, Marico, Axis Bank, Trent and Zydus Lifesciences AI summary · NEUTRAL
· Indian equity markets showed signs of recovery on Monday. · The Nifty 50 index ended the session up. · Investors are watching key corporate updates from companies like Vedanta and Kotak Mahindra Bank. VERIFIED Mint Markets · 9d ★ ON YOUR LIST ☆
Zydus hits 52-week high, can the optimism continue? AI summary · POSITIVE
· Zydus Lifesciences has seen a 32% increase in its stock value in 2026. · Favorable US FDA inspections, resilient India growth, and a strong pipeline have contributed to the stock's performance. · Potential risks include weakness in the US market and pressure on profit margins. VERIFIED Mint Markets · 10d ★ ON YOUR LIST ☆
Top stocks to watch today: Why IRFC, Ola, NCC, Tata stocks must be on radar? Full list for Tuesday, 29 September AI summary · NEUTRAL
· Indian Railway Finance Corporation (IRFC) is among the stocks likely to remain in focus on Tuesday. · Tata Group stocks are also expected to be in focus. · Ola Electric Mobility and NCC are among the other stocks that may be watched on Tuesday. VERIFIED ET Markets · 10d ★ ON YOUR LIST ☆
Stocks in news: Tata Group, ITC, IRFC, NCC, Zydus Lifesciences and JSW Energy AI summary · NEGATIVE
· The Indian equity markets experienced a significant downturn, with benchmark indices falling below vital support levels. · The Nifty 50 declined by 360.25 points, indicating heightened investor anxiety. · Tata Group, ITC, and Indian Railway Finance Corporation are among the key companies drawing attention due to recent news. VERIFIED Mint Markets · 11d ★ ON YOUR LIST ☆
Top stocks in focus today: Investors must watch Power Grid, Cupid, SAIL shares on Monday, 28 Sept | Triggers AI summary · NEUTRAL
· SAIL, Power Grid, KPI Green Energy, Godrej Properties, and Zydus Lifesciences are expected to be in focus. · These companies are likely to attract investor attention. · The focus is due to announcements made by these companies. VERIFIED Mint Markets · 13d ★ ON YOUR LIST ☆
Indian stock market slides, but 28 Nifty 500 stocks hit fresh 1-year highs this week; MCX, PVR Inox among them AI summary · NEUTRAL
· The Nifty 50 index saw its largest weekly drop since 2020, falling by 0.88%. · Despite the overall market downturn, 28 stocks within the Nifty 500 index reached new 1-year highs this week. · Notable stocks that hit fresh peaks include MCX and PVR Inox, alongside Welspun Corp and Zydus Lifesciences. VERIFIED ET Stocks · 13d ★ ON YOUR LIST ☆
Engineers India among 7 stocks hitting 52-week highs; shares rallied up to 25% in a month AI summary · POSITIVE
· Seven BSE 500 stocks, including Engineers India, Welspun Corp, and Zydus Lifesciences, reached new 52-week highs on Friday. · Engineers India was among the stocks that touched a fresh 52-week high. · These stocks have seen rallies of up to 25% in the past month. Google News, NIFTY/SENSEX · 13d ★ ON YOUR LIST ☆
Welspun Corp., MCX to Zydus Life: Top five Nifty 500 stocks that hit 52-week high on Sept 25; check full list - Upstox Summarize with AI → VERIFIED ET Finance · 15d ★ ON YOUR LIST ☆
Zydus Lifesciences expects decent growth for five years as innovation matures: Sharvil Patel AI summary · POSITIVE
· Zydus Lifesciences aims for double-digit revenue growth and improved profitability over the next five years. · The company plans to focus on specialty medicines and biotechnology innovation, enhancing its oncology franchise. · Discovery-led products are expected to contribute from 2030 onwards, strengthening its market position. VERIFIED ET Finance · 15d ★ ON YOUR LIST ☆
Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD AI summary · POSITIVE
· Zydus expects strong earnings from its discovery-led business, oncology, and Saroglitazar from 2030 onwards. · The company anticipates significant value creation from these areas within the next four to five years. · Zydus is exploring new business areas for future growth. VERIFIED ET Stocks · 30d ★ ON YOUR LIST ☆
Supreme Industries among 4 stocks showing RSI trending up AI summary · POSITIVE
· Supreme Industries, Zydus Lifesciences, Narayana Hrudayalaya, and Nippon Life India AMC are four Nifty500 stocks with rising RSI above 50. · This indicates strengthening momentum for these stocks. · The rising RSI suggests potential uptrend conditions. VERIFIED ET Markets · 30d ★ ON YOUR LIST ☆
Supreme Industries among 4 stocks showing RSI trending up AI summary · POSITIVE
· Supreme Industries, Zydus Lifesciences, Narayana Hrudayalaya, and Nippon Life India AMC are four Nifty500 stocks with rising RSI above 50. · A rising RSI above 50 indicates strengthening momentum. · This suggests potential uptrend conditions for these stocks. Google News, NIFTY/SENSEX · 31d ★ ON YOUR LIST ☆
HEG Advanced Materials, ESDS, Maruti Suzuki, Zydus Wellness among buzzing stocks as NIFTY, SENSEX down 0.6% - Upstox Summarize with AI → Google News, NIFTY/SENSEX · 31d ★ ON YOUR LIST ☆
Zydus Wellness up 8%, PVR Inox down 7%: Check out other Nifty 500 top movers - CNBC TV18 - LinkedIn Summarize with AI → VERIFIED Mint Markets · 31d ★ ON YOUR LIST ☆
Volume shocker stocks today: Why Innovassynth, RIR Power, Pashupati Cotspin, Zydus Wellness are soaring - Data details h AI summary · POSITIVE
· Innovassynth, RIR Power, Pashupati Cotspin, and Zydus Wellness saw a surge in volume on Monday, September 7. · The stocks experienced a jump in trading volume during morning deals. · This increase in volume coincided with a rise in their stock prices. VERIFIED ET Finance · 38d ★ ON YOUR LIST ☆
Zydus’ Saroglitazar meets primary goal in global Phase II(b) MASH trial AI summary · NEUTRAL
· Zydus Lifesciences announced its drug Saroglitazar Magnesium achieved its primary objective in a global Phase II(b) trial. · The trial focused on MASH, a severe liver condition associated with metabolic disorders. · Saroglitazar Magnesium is being tested for its efficacy in treating MASH. VERIFIED ET Stocks · 41d ★ ON YOUR LIST ☆
Holy trinity! Promoters, FIIs and mutual funds raised stakes in these 9 stocks; 3 turned multibaggers AI summary · POSITIVE
· Promoters, FIIs, and mutual funds increased their stakes in nine Indian stocks. · Cupid stock delivered a 732% return in the past year. · United Foodbrands and Yasho Industries also showed strong performance. VERIFIED ET Stocks · 44d ★ ON YOUR LIST ☆
Muthoot Finance among 6 stocks flashing bullish signals, hinting at a possible uptrend AI summary · POSITIVE
· Six Nifty500 stocks, including Muthoot Finance, PTC Industries, Siemens, HFCL, Zydus Wellness, and Engineers India, showed bullish signals. · These stocks formed White Marubozu patterns. · The patterns indicate strong buying pressure and bullish momentum observed during Monday's trading session. VERIFIED ET Finance · 48d ★ ON YOUR LIST ☆
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injection AI summary · POSITIVE
· Zydus Lifesciences has received final USFDA approval for its generic ascorbic acid injection. · The injection is approved for the treatment of scurvy in specific patient groups. · The USFDA designated this application as a Competitive Generic Therapy. VERIFIED ET Finance · 56d ★ ON YOUR LIST ☆
Delhi HC backs Zydus in trademark row AI summary · POSITIVE
· The Delhi High Court upheld a ruling against Alder Biochem regarding the 'Biochem' trademark. · Alder Biochem's argument that 'Biochem' is public property was dismissed by the court. · Zydus Healthcare's registered trademark, held since 1959, is protected by this decision. VERIFIED ET Markets · 56d ★ ON YOUR LIST ☆
Lenskart Solutions among 7 stocks hitting 52-week highs; surge up to 20% in a month AI summary · POSITIVE
· Seven BSE 200 stocks reached new 52-week highs on a day the Sensex increased by 113 points. · Paytm saw the largest monthly increase at 19%. · Other stocks reaching 52-week highs included Bosch, Lenskart Solutions, Aurobindo Pharma, Pidilite, Solar Industries India, and Zydus Lifesciences. VERIFIED ET Stocks · 57d ★ ON YOUR LIST ☆
Stocks to buy in 2026 for long term: Siemens, Zydus Lifesciences among 5 stocks that could give 10-20% return AI summary · NEUTRAL
· Siemens and Zydus Lifesciences are among five stocks identified for potential 10-20% returns by 2026. · The recommendations are based on insights from top brokerage firms and other sources. · The article focuses on stocks suitable for long-term investment. VERIFIED ET Stocks · 57d ★ ON YOUR LIST ☆
Zydus Lifesciences shares drop 3% after Q1 earnings. Here's why Nuvama upgraded rating, hiked target AI summary · NEGATIVE
· Zydus Lifesciences reported a 36% year-on-year drop in net profit for Q1. · Operational revenue increased by nearly 22%, while expenses surged over 41%. · Nuvama upgraded the stock to 'Buy' and raised its price target. VERIFIED ET Markets · 58d ★ ON YOUR LIST ☆
Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 crore AI summary · NEGATIVE
· Zydus Lifesciences reported a 36% year-on-year decline in net profit for Q1, reaching Rs 939.8 crore. · Operational revenue increased by 22% to Rs 8,017 crore. · EBITDA saw a 7.6% reduction compared to the previous year. VERIFIED ET Stocks · 58d ★ ON YOUR LIST ☆
Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 crore AI summary · NEGATIVE
· Zydus Lifesciences reported a 36% year-on-year decline in net profit for Q1, reaching Rs 939.8 crore. · Operational revenue increased by 22% to Rs 8,017 crore. · EBITDA saw a 7.6% reduction compared to the previous year. VERIFIED Mint Markets · 58d ★ ON YOUR LIST ☆
Q1 results 2026: RVNL to MRF among companies to declare Q1 results today; full list here AI summary · NEUTRAL
· Rail Vikas Nigam, MRF, Zydus Lifesciences, NBCC (India), Senco Gold, and Manappuram Finance will report their Q1 FY27 results today. · The companies are scheduled to declare their financial results for the first quarter of the fiscal year 2027. · This list includes a diverse range of sectors within the Indian stock market. VERIFIED Mint Markets · 78d ★ ON YOUR LIST ☆
Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines import AI summary · NEGATIVE
· Several Indian pharmaceutical companies experienced a decline in their stock prices. · Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma, and Zydus Lifesciences were among the top decliners. · The decline occurred following a plan by Donald Trump regarding tariffs on generic medicine imports. Google News, NIFTY/SENSEX · 81d ★ ON YOUR LIST ☆
Nifty outlook: Buy the dips, says Angel One; prefers PTC Ind, Zydus Life - Business Standard Summarize with AI →